Study Design Flashcards
double blind
both experimenter and subjects are blinded
crossover study
Each study participant receives all treatments that are being investigated but at different times
Order of treatments is randomized
Washout often included between treatments
partial crossover or incomplete block
In some crossover designs, particularly ones with more than 2 treatments, patients may not receive all treatments under investigation, but would receive more than 1
Pros of Crossover Study Design
Each patient serves as their own control.
Reduces between-subject variability.
Allows for detection of smaller effect sizes with reduced sample sizes.
Effect Size
Quantitative measure of the magnitude of a phenomenon (eg. the correlation between 2 variables)
Small effect size is one in which there is a real effect, i.e. something is really happening in the world - but which you can only see through careful study.
Parallel Study
Two groups of treatments: A & B
One group receives only A, other group receives only B
Longitudinal Study
Repeated observations of the same variables over short or long periods of time.
Often observational but can be structured as longitudinal randomized experiments.
Large Effect Size
Can be seen by the naked eye, easily observed.
Small Effect Size
There is a real effect, i.e. something is really happening in the world - but which you can only see through careful study.
Confounders
Variable that influences both dependent and independent variables.
Why is the influence of confounders reduced in crossover studies?
Each patient is their own control.
Optimal crossover designs require ________ subjects.
fewer
Which patient population best aligns with crossover study design?
Crossover studies are often done to improve symptoms of patients with chronic conditions.
May be infeasible or unethical for curative treatments or rapidly changing conditions.
What are two main issues with crossover studies?
- “Order” Effects. Order of treatment may effect outcome, eg. drug with many adverse effects given first, making patients taking a 2nd, less harmful medication, more sensitive to any adverse effects.
- “Carry-over”. Carry-over between treatments which confounds estimates of treatment effects. In practice “carry-over” effects can be avoided with a sufficiently long “wash-out” period between treatments. However, planning for sufficently long wash-out periods requires expert knowledge of the dynamics of the treatment, which is often unknown.